magalon@tec.mx
selected publications
-
academic article
-
academic article in scopus
- miRNA signature associated with R¿CHOP refractoriness in patients diagnosed with diffuse large B cell lymphoma. Non-coding RNA Research. 5:185-190. 2020
- Neurotrophic Factors and Their Receptors Are Altered by the Mere Partial IGF-1 Deficiency. Neuroscience. 404:445-458. 2019
- A 42-year-old woman with untreated growth hormone insensitivity, diabetic retinopathy, and gene sequencing identifies a variant of laron syndrome. American Journal of Case Reports. 20:689-696. 2019
- Primary growth hormone insensitivity and psychomotor delay. Clinical Case Reports. 6:426-431. 2018
- Mexican case report of a never-treated Laron syndrome patient evolving to metabolic syndrome, type 2 diabetes, and stroke. Clinical Case Reports. 5:1852-1855. 2017
- Experimental approach to IGF-1 therapy in CCl4-induced acute liver damage in healthy controls and mice with partial IGF-1 deficiency. Journal of Translational Medicine. 15. 2017
- Fanconi Anemia and Laron Syndrome. American Journal of the Medical Sciences. 353:425-432. 2017
- IGF-1 modulates gene expression of proteins involved in inflammation, cytoskeleton, and liver architecture. Journal of Physiology and Biochemistry. 73:245-258. 2017
- Partial IGF-1 deficiency induces brain oxidative damage and edema, which are ameliorated by replacement therapy. BioFactors. 42:60-79. 2016
- Mechanisms Underlying Testicular Damage and Dysfunction in Mice with Partial IGF-1 Deficiency and the Effectiveness of IGF-1 Replacement Therapy. Urology. 86:1241.e1-1241.e9. 2015
- Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: An experimental approach to metabolic syndrome. Journal of Translational Medicine. 13. 2015